# Corrigendum to ‘B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis’ [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]

**Authors:** Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel J.M. Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert A. Trouw, Bart van Hoek

PMC · DOI: 10.1016/j.jhepr.2025.101447 · JHEP Reports · 2025-06-03

## Full-text entities

- **Genes:** TNFSF13B (TNF superfamily member 13b) [NCBI Gene 10673] {aka BAFF, BLYS, CD257, TALL-1, TALL1, THANK}, IL21 (interleukin 21) [NCBI Gene 59067] {aka CVID11, IL-21, Za11}
- **Diseases:** autoimmune hepatitis (MESH:D019693)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12167470/full.md

---
Source: https://tomesphere.com/paper/PMC12167470